Searched over 200M research papers for "embolic cva"
10 papers analyzed
These studies suggest that embolic cerebrovascular accidents (CVA) can be influenced by factors such as the type of inflow conduit in ventricular assist systems, underlying conditions like Ebstein's anomaly, and the presence of malignancies, while inflammation appears more related to thrombotic CVA.
20 papers analyzed
Embolic cerebrovascular accidents (CVA), commonly known as strokes, occur when a blood clot or other debris forms away from the brain—commonly in the heart—and is swept through the bloodstream to lodge in narrower brain arteries. This type of stroke can lead to significant neurological damage and requires immediate medical attention.
Mechanical circulatory support devices, such as the Novacor left ventricular assist system (LVAS), have been associated with embolic complications. Studies have shown that the type of inflow conduit (IFC) used in these devices can significantly impact the incidence of embolic CVA. For instance, an alternative IFC design (knitted, gelatin-sealed, integrally supported, uncrimped polyester) has been shown to reduce the incidence of embolic CVA from 21% to 12% compared to the original IFC design (woven, unsupported, crimped polyester). Similarly, the introduction of an expanded polytetrafluoroethylene (ePTFE) inflow conduit has demonstrated a significant decrease in embolic CVA incidence, with a 55% risk reduction compared to polyester conduits.
Patients with congenital heart defects, such as Ebstein's anomaly (EA), are at a higher risk for embolic CVA. A study involving 968 EA patients found that 9% had a history of CVA, with paradoxical embolism being a significant contributing factor. The presence of atrial septal defects or patent foramen ovale (PFO) and a history of migraines or headaches were identified as significant risk factors for CVA in these patients. Additionally, hypercoagulation states in patients with PFO do not appear to be a direct risk factor for embolic CVA, suggesting that other mechanisms, such as paradoxical emboli, play a more critical role.
Cardiac conditions, including left ventricular thrombus and atrial fibrillation, are well-known risk factors for embolic CVA. For example, left ventricular thrombi, often observed after myocardial infarction, can lead to embolic strokes even in the absence of typical risk factors like left ventricular aneurysm . Furthermore, patients undergoing procedures like transcatheter aortic valve replacement (TAVR) are at risk for both early and late CVAs, with atrial fibrillation and prior cerebrovascular disease being significant predictors.
The recovery and management of patients with cardio-embolic stroke require a comprehensive, multidisciplinary approach. This includes addressing all associated pathologies, such as diabetes mellitus, which can influence patient outcomes. A case study highlighted the importance of a multidisciplinary team in improving functional outcomes for a patient with hemiplegia following an ischemic cardio-embolic stroke.
Preventive strategies for embolic CVA include the use of embolic protection devices during procedures like TAVR, antithrombotic treatments, and aggressive management of modifiable risk factors. Improved interventional techniques and close monitoring are also crucial in reducing the incidence of embolic CVA.
Embolic CVA is a complex condition influenced by various factors, including mechanical circulatory support devices, congenital heart defects, and cardiac conditions. Understanding these risk factors and implementing comprehensive management and preventive strategies are essential in reducing the incidence and improving outcomes for patients with embolic CVA.
Most relevant research papers on this topic